Canadian Urological Association Consensus Guideline: Management of Testicular Germ Cell Cancer

Overview

Journal Can Urol Assoc J

Specialty Urology

Date 2022 May 27

PMID 35623007

Authors

Robert J Hamilton

Christina Canil

Noa Shani Shrem

Kopika Kuhathaas

Maria Di Jiang

Peter Chung

Scott North

Piotr Czaykowski

Sebastien Hotte

Eric Winquist

Christian Kollmannsberger

Armen Aprikian

Denis Soulieres

Scott Tyldesley

Alan I So

Nicholas Power

Ricardo A Rendon

Martin OMalley

Lori Wood

Affiliations

Soon will be listed here.

Citing Articles

Case report: A case with atypical presentation oftesticular choriocarcinoma.

Zhong B, Zhang T, Dong Y, Yin W, Zhang J, Jin W Front Oncol. 2024; 14:1223873.

PMID: 39099693 PMC: 11294831. DOI: 10.3389/fonc.2024.1223873.

Restricted access and advanced disease in post-pandemic testicular cancer.

Fagan M, Janes W, Andrews M, Harvey D, Warden G, Organ M Can Urol Assoc J. 2024; 18(8):262-267.

PMID: 38587978 PMC: 11326728. DOI: 10.5489/cuaj.8648.

Pure testicular choriocarcinoma, a rare and highly malignant subtype with challenging treatment: A case report and review of the literature.

Lei N, Lei L, Wang C, Mei C Mol Clin Oncol. 2024; 20(1):1.

PMID: 38223403 PMC: 10784770. DOI: 10.3892/mco.2023.2699.

The Use of Salvage Chemotherapy for Patients with Relapsed Testicular Germ Cell Tumor (GCT) in Canada: A National Survey.

Al-Ezzi E, Zahralliyali A, Hansen A, Hamilton R, Crump M, Kuruvilla J Curr Oncol. 2023; 30(7):6166-6176.

PMID: 37504318 PMC: 10378146. DOI: 10.3390/curroncol30070458.

Accuracy of germ cell tumor histology and stage within a Canadian cancer registry.

Holland P, Karmas E, Merrimen J, Wood L Can Urol Assoc J. 2022; 17(2):44-48.

PMID: 36218319 PMC: 9970644. DOI: 10.5489/cuaj.8030.

References

Aass N, Klepp O, Cavallin-Stahl E, Dahl O, WICKLUND H, UNSGAARD B . Prognostic factors in unselected patients with nonseminomatous metastatic testicular cancer: a multicenter experience. J Clin Oncol. 1991; 9(5):818-26. DOI: 10.1200/JCO.1991.9.5.818. View

Sheinfeld J, Motzer R, Rabbani F, McKiernan J, Bajorin D, Bosl G . Incidence and clinical outcome of patients with teratoma in the retroperitoneum following primary retroperitoneal lymph node dissection for clinical stages I and IIA nonseminomatous germ cell tumors. J Urol. 2003; 170(4 Pt 1):1159-62. DOI: 10.1097/01.ju.0000087822.71739.9a. View

Hotte S, Mayhew L, Jewett M, Chin J, Winquist E . Management of stage I non-seminomatous testicular cancer: a systematic review and meta-analysis. Clin Oncol (R Coll Radiol). 2009; 22(1):17-26. DOI: 10.1016/j.clon.2009.09.005. View

Oechsle K, Hartmann M, Brenner W, Venz S, Weissbach L, Franzius C . [18F]Fluorodeoxyglucose positron emission tomography in nonseminomatous germ cell tumors after chemotherapy: the German multicenter positron emission tomography study group. J Clin Oncol. 2008; 26(36):5930-5. DOI: 10.1200/JCO.2008.17.1157. View

Gillessen S, Sauve N, Collette L, Daugaard G, de Wit R, Albany C . Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium. J Clin Oncol. 2021; 39(14):1563-1574. PMC: 8099402. DOI: 10.1200/JCO.20.03296. View

Heidenreich A, Albers P, Hartmann M, Kliesch S, Kohrmann K, Krege S . Complications of primary nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis: experience of the German Testicular Cancer Study Group. J Urol. 2003; 169(5):1710-4. DOI: 10.1097/01.ju.0000060960.18092.54. View

Mead G, Fossa S, Oliver R, Joffe J, Huddart R, Roberts J . Randomized trials in 2466 patients with stage I seminoma: patterns of relapse and follow-up. J Natl Cancer Inst. 2011; 103(3):241-9. DOI: 10.1093/jnci/djq525. View

Albers P, Siener R, Krege S, Schmelz H, Dieckmann K, Heidenreich A . Randomized phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I Nonseminomatous testicular germ cell tumors: AUO trial AH.... J Clin Oncol. 2008; 26(18):2966-72. DOI: 10.1200/JCO.2007.12.0899. View

Baniel J, Foster R, GONIN R, Messemer J, Donohue J, Einhorn L . Late relapse of testicular cancer. J Clin Oncol. 1995; 13(5):1170-6. DOI: 10.1200/JCO.1995.13.5.1170. View

10.

Stephenson A, Eggener S, Bass E, Chelnick D, Daneshmand S, Feldman D . Diagnosis and Treatment of Early Stage Testicular Cancer: AUA Guideline. J Urol. 2019; 202(2):272-281. DOI: 10.1097/JU.0000000000000318. View

11.

Pierorazio P, Cheaib J, Patel H, Gupta M, Sharma R, Zhang A . Comparative Effectiveness of Surveillance, Primary Chemotherapy, Radiotherapy and Retroperitoneal Lymph Node Dissection for the Management of Early Stage Testicular Germ Cell Tumors: A Systematic Review. J Urol. 2020; 205(2):370-382. DOI: 10.1097/JU.0000000000001364. View

12.

Heidenreich A, Pfister D, Witthuhn R, Thuer D, Albers P . Postchemotherapy retroperitoneal lymph node dissection in advanced testicular cancer: radical or modified template resection. Eur Urol. 2008; 55(1):217-24. DOI: 10.1016/j.eururo.2008.09.027. View

13.

De Giorgi U, Demirer T, Wandt H, Taverna C, Siegert W, Bornhauser M . Second-line high-dose chemotherapy in patients with mediastinal and retroperitoneal primary non-seminomatous germ cell tumors: the EBMT experience. Ann Oncol. 2004; 16(1):146-51. DOI: 10.1093/annonc/mdi017. View

14.

Frankel J, Caumont F, DeBerg H, Flores J, Porter C . Contemporary trends in management of stage 1 seminoma. Urol Oncol. 2021; 39(4):240.e1-240.e8. DOI: 10.1016/j.urolonc.2020.08.025. View

15.

Kondagunta G, Bacik J, Donadio A, Bajorin D, Marion S, Sheinfeld J . Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors. J Clin Oncol. 2005; 23(27):6549-55. DOI: 10.1200/JCO.2005.19.638. View

16.

Suleiman Y, Siddiqui B, Brames M, Abonour R, Einhorn L . Salvage therapy with high-dose chemotherapy and peripheral blood stem cell transplant in patients with primary mediastinal nonseminomatous germ cell tumors. Biol Blood Marrow Transplant. 2012; 19(1):161-3. DOI: 10.1016/j.bbmt.2012.08.002. View

17.

von der Maase H, Specht L, Jacobsen G, Jakobsen A, Madsen E, Pedersen M . Surveillance following orchidectomy for stage I seminoma of the testis. Eur J Cancer. 1993; 29A(14):1931-4. DOI: 10.1016/0959-8049(93)90446-m. View

18.

Daugaard G, Gundgaard M, Mortensen M, Agerbaek M, Holm N, Rorth M . Surveillance for stage I nonseminoma testicular cancer: outcomes and long-term follow-up in a population-based cohort. J Clin Oncol. 2014; 32(34):3817-23. DOI: 10.1200/JCO.2013.53.5831. View

19.

Besse B, Grunenwald D, Flechon A, Caty A, Chevreau C, Culine S . Nonseminomatous germ cell tumors: assessing the need for postchemotherapy contralateral pulmonary resection in patients with ipsilateral complete necrosis. J Thorac Cardiovasc Surg. 2009; 137(2):448-52. DOI: 10.1016/j.jtcvs.2008.09.032. View

20.

Honecker F, Aparicio J, Berney D, Beyer J, Bokemeyer C, Cathomas R . ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up. Ann Oncol. 2018; 29(8):1658-1686. DOI: 10.1093/annonc/mdy217. View